Search
There were a total of 27 results for your search.
Pirbright generates first pig flu antibodies that could improve human treatments and guide flu vaccine selection
The Pirbright Institute has generated the first pig antibodies against swine influenza (flu) that protect against infection and recognise the same parts of the flu virus as human antibodies. This...
Type: News
Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM)
About Globally there is a gap in the capacity to translate scientific discoveries into solutions for the most challenging, emerging, and urgent infectious diseases. Translating innovative ideas from...
Type: Page
Veterinary Vaccine Centre welcomed in White Paper
The expertise of the Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM) at The Pirbright Institute has been recognised in a Government White Paper aimed at ending world hunger. CVIM is...
Type: News
Pirbright research to boost vaccine production
Scientists at The Pirbright Institute have received money which will enable research into boosting vaccine yields by up to ten fold. The funding was awarded by the Livestock Vaccine Innovation Fund...
Type: News
Director's vision
Pirbright has seen immense change and exceptional scientific achievement in recent years, bringing major breakthroughs in our understanding of virus and host interaction. Many have been achieved...
Type: Page
Pigs ideal for assessing flu antibody therapies, say Pirbright scientists
Studies undertaken at The Pirbright Institute in collaboration with Inovio Pharmaceuticals have shown that pigs can be used to assess whether influenza antibody therapies are effective, which could...
Type: News
Pirbright generates first pig flu antibodies that could improve human treatments and guide flu vaccine selection
The Pirbright Institute has generated the first pig antibodies against swine influenza (flu) that protect against infection and recognise the same parts of the flu virus as human antibodies. This...
Type: Press release
Pigs as universal flu vaccine models
Researchers from The Pirbright Institute collaborated with the University of Oxford and the National Institutes of Health, USA, to show that S-FLU, a universal flu vaccine candidate, induces...
Type: News
Pirbright scientists use ‘molecular magnets’ to discover FMD virus segments that could improve vaccine effectiveness
Recent research from The Pirbright Institute has revealed new parts of the foot-and-mouth disease virus (FMDV) that stimulate an immune response, which could be used to inform the design of improved...
Type: News
Pirbright reveals true cost of goat plague vaccination campaigns
A study led by The Pirbright Institute has created the first framework for determining the true cost of peste des petits ruminants (PPR) vaccine campaigns based on case studies in Ethiopia. PPR, also...
Type: News